Arrhythmias & EP
News from the FDA/CDC
Cell phone, smart watch magnets can affect medical devices, FDA says
Conference Coverage
ACC 21 looks to repeat success despite pandemic headwinds
Plans for a hybrid meeting this year have pivoted again to fully virtual, but the focus on connection, education, and late-breaking science...
Latest News
Coffee intake may be driven by cardiovascular symptoms
Observational results show those with hypertension, angina, or arrhythmia drink less coffee than others, which may explain mixed results in...
News
FDA blazes path for ‘real-world’ evidence as proof of efficacy
FDA leaders must finalize guidance this year on submitting real-world observational evidence for regulatory decisions on drug and device efficacy...
Feature
A ‘mess’ of a diagnosis: Is it type 2 MI or a nonischemic imposter?
Often tough to tell apart and with surprisingly poor prognoses, type 2 MI and nonischemic myocardial injury lack trials to guide therapy. Whether...
Conference Coverage
Modest clinical gain for AF screening of asymptomatic elderly: STROKESTOP
Literally all known 75- and 76-year-olds in two Swedish regions were included, whether or not they were screened by mobile ECG recorder. But does...
From the Journals
Post–COVID-19 cardiac involvement in college athletes much rarer than thought
A prospective registry with more than 3,000 COVID-19–positive athletes shows incidence of cardiac involvement of less than 1% with no adverse...
Guidelines
AHA statement on obesity emphasizes abdominal fat, AFib
Updated guidance on obesity and cardiovascular disease focuses on abdominal adiposity as a cardiovascular risk factor.
News
Medtronic recall of almost 240,000 ICDs is class I, FDA says
The recall applies to implantable defibrillators, with and without resynchronization pacing, that are at apparent risk for premature and possibly...
From the Journals
Remote cardio visits expand access for underserved during COVID
In a cross-sectional study of more than 170,000 ambulatory cardiology visits, patients using remote visits were more likely to be Asian, Black, or...
From the Journals
Dose-related AFib risk with omega-3 fatty acids?
The VITAL-RHYTHM study, showing no significant effect of low-dose omega-3 fatty acids or vitamin D on AFib risk, has been published. A look at...